Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down SyndromeKatherine A. Waugh, Joaquı́n M. Espinosa, Kelley L. Colvin et al.|Cell Reports|2019Cited by 148
Specialized interferon action in COVID-19Matthew D. Galbraith, Joaquı́n M. Espinosa, Kohl T. Kinning et al.|Proceedings of the National Academy of Sciences|2022Cited by 94
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D. Galbraith, Joaquı́n M. Espinosa, Angela L. Rachubinski et al.|Science Advances|2023Cited by 83
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variantsKathleen Baysac, Michael J. Ombrello, Ankur Kumar Jindal et al.|Journal of Allergy and Clinical Immunology|2023Cited by 53
The COVIDome Explorer researcher portalKelly D. Sullivan, Joaquı́n M. Espinosa, Matthew D. Galbraith et al.|Cell Reports|2021Cited by 47